NO882065D0 - Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne. - Google Patents

Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne.

Info

Publication number
NO882065D0
NO882065D0 NO882065A NO882065A NO882065D0 NO 882065 D0 NO882065 D0 NO 882065D0 NO 882065 A NO882065 A NO 882065A NO 882065 A NO882065 A NO 882065A NO 882065 D0 NO882065 D0 NO 882065D0
Authority
NO
Norway
Prior art keywords
diarylalkyl
procedure
preparation
products containing
medicinal products
Prior art date
Application number
NO882065A
Other languages
English (en)
Other versions
NO882065L (no
Inventor
Wolfgang Rueger
Hansjoerg Urbach
Joachim Kaiser
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO882065D0 publication Critical patent/NO882065D0/no
Publication of NO882065L publication Critical patent/NO882065L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paints Or Removers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
NO882065A 1987-05-12 1988-05-11 Diarylalkyl-substituerte alkylaminer, fremgangsmaate for fremstilling av dem, anvendelse av dem, saavel som legemidler som inneholder dem. NO882065L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715763 DE3715763A1 (de) 1987-05-12 1987-05-12 Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
NO882065D0 true NO882065D0 (no) 1988-05-11
NO882065L NO882065L (no) 1988-11-14

Family

ID=6327331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882065A NO882065L (no) 1987-05-12 1988-05-11 Diarylalkyl-substituerte alkylaminer, fremgangsmaate for fremstilling av dem, anvendelse av dem, saavel som legemidler som inneholder dem.

Country Status (14)

Country Link
US (1) US4933346A (no)
EP (1) EP0290958A3 (no)
JP (1) JPS63297358A (no)
KR (1) KR880013893A (no)
CN (1) CN88102650A (no)
AU (1) AU1605588A (no)
DE (1) DE3715763A1 (no)
DK (1) DK259088A (no)
FI (1) FI882177A (no)
HU (1) HUT46897A (no)
IL (1) IL86361A0 (no)
NO (1) NO882065L (no)
PT (1) PT87456B (no)
ZA (1) ZA883342B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686438B2 (ja) * 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053301A (no) * 1963-01-14
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
GB1546238A (en) * 1976-04-07 1979-05-23 Serdex Soc D Etudes De Rech De Piperazine derivatives a process for their preparation and their applications
CH643549A5 (de) * 1979-08-25 1984-06-15 Merz & Co N-(trimethoxybenzyl)-n'-phenylpiperazine.
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
DE3529994A1 (de) * 1985-08-22 1987-02-26 Hoechst Ag Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
NO882065L (no) 1988-11-14
EP0290958A3 (de) 1990-08-08
PT87456B (pt) 1992-09-30
KR880013893A (ko) 1988-12-22
FI882177A0 (fi) 1988-05-10
AU1605588A (en) 1988-11-17
HUT46897A (en) 1988-12-28
DE3715763A1 (de) 1988-11-24
FI882177A (fi) 1988-11-13
IL86361A0 (en) 1988-11-15
CN88102650A (zh) 1988-12-14
US4933346A (en) 1990-06-12
PT87456A (pt) 1989-05-31
DK259088A (da) 1988-11-13
DK259088D0 (da) 1988-05-11
EP0290958A2 (de) 1988-11-17
JPS63297358A (ja) 1988-12-05
ZA883342B (en) 1988-11-16

Similar Documents

Publication Publication Date Title
NO870078D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse samt legemidler som inneholder de.
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK310383A (da) 14-fluormorphinaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK55188D0 (da) Alkylsubstituerede n-benzopyranyllactamer, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK661288A (da) Iminophenylthiazolidiner, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DK468487D0 (da) Aminoglycosidsteroider, en fremgangsmaade til deres fremstilling, deres anvendelse samt farmaceutiske praeparater der indeholder dem.
NO882065D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne.
DK393788D0 (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK361288A (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO881775L (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.
DK260884A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK570388A (da) Pyridylphosphater, fremgangsmaade til deres fremstilling samt deres anvendelse som pesticider
DK348388A (da) Sulfonylurinstofforbindelser, fremgangsmaade til deres fremstilling, samt deres anvendelser som ukrudtsbekaempelsesmidler
DK321387A (da) Cytorhodin s-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK367887D0 (da) Arylethanolhydroxylaminer, deres fremstilling og anvendelse samt mellemprodukter til fremstilling ogdisses fremstilling
DK264788D0 (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK134083A (da) 7-alfa-aminoacyl-3-chlorcephalosporiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO880285D0 (no) Sparsomycin (sc-rs)forbindelser med antitumoraktivitet, fremgangsmaate til fremstilling derav samt farmasoeytisk preparat som inneholder forbindelsene.